MARS1 (methionyl-tRNA synthetase 1) encodes an essential enzyme that catalyzes the specific attachment of methionine to its cognate tRNA in a two-step reaction involving ATP activation followed by transfer to the tRNA acceptor end 1. Beyond its canonical role in protein translation, MARS1 plays important roles in ribosomal RNA synthesis in the nucleolus 2. The enzyme has emerged as a critical regulator of inflammation through its interaction with homocysitaconate, a metabolite that binds to MARS1's D312 residue and inhibits its function, thereby reshaping methionine metabolism and controlling inflammatory responses via the NLRP3 pathway 3. MARS1 also responds to homocysteine by producing homocysteine thiolactone, which promotes N-homocysteinylation of proteins including HMGB1/2, contributing to endothelial senescence and dysfunction 4. Clinically, MARS1 mutations cause severe multisystemic diseases including interstitial lung and liver disease, Charcot-Marie-Tooth disease type 2U, and spastic paraplegia 70 5. Patients with MARS1 mutations typically present with anemia, hepatomegaly, feeding difficulties, and failure to thrive 5. Interestingly, MARS1 expression patterns are also used in sepsis subtyping strategies, though these show limited concordance with other classification systems 6.